The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017Farin Kamangar, Pawan Faris, Hassan Abolhassani et al.|The Lancet. Gastroenterology & hepatology|2020Cited by 643
Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trialGholamreza Roshandel, Reza Malekzadeh, Masoud Khoshnia et al.|The Lancet|2019Cited by 284
Individual and Combined Effects of Environmental Risk Factors for Esophageal Cancer Based on Results From the Golestan Cohort StudyMahdi Sheikh, Reza Malekzadeh, Hossein Poustchi et al.|Gastroenterology|2019Cited by 183
Opium use and subsequent incidence of cancer: results from the Golestan Cohort StudyMahdi Sheikh, Reza Malekzadeh, Ramin Shakeri et al.|The Lancet Global Health|2020Cited by 108
Urinary TERT promoter mutations are detectable up to 10 years prior to clinical diagnosis of bladder cancer: Evidence from the Golestan Cohort StudyMd. Ismail Hosen, Florence Le Calvez‐Kelm, Mahdi Sheikh et al.|EBioMedicine|2020Cited by 84